Cost and Cost-Effectiveness Analyses of the PULESA Trial to Integrate HIV and Hypertension Care in Urban and Peri-Urban Uganda

The PULESA-Uganda trial is a stepped-wedge, cluster randomized trial evaluating the effectiveness, implementation, cost and cost-effectiveness of integrating hypertension care into public and private-not-for-profit HIV clinics in the Kampala and Wakiso Districts of Uganda. The study compares two implementation strategies: HTN-BASIC (providing access to essential hypertension management tools and drugs) and HTN-PLUS (adding advanced training, remote monitoring, and performance feedback). It targets improving hypertension outcomes (12-month controlled blood pressure) for people living with HIV (PLHIV). PULESA addresses critical gaps in care by focusing on integration, affordability, and enhanced service delivery​. The Tobin fellow would work closely with the study co-investigator and a current RA to clean and analyze patient and provider cost data, time-and-motion data and produce literature reviews. Fellow may be asked to produce tables of basic descriptive statistics, conduct basic econometric analyses, or other tasks.